Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
10
PRQR Quote, Financials, Valuation and Earnings
Last price:
$2.65
Seasonality move
:
2.98%
Day range:
$2.48 - $2.71
52-week range:
$1.61 - $4.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.17x
P/B ratio:
10.08x
Volume:
547.3K
Avg. volume:
638.1K
1-year change:
35.46%
Market cap:
$281.2M
Revenue:
$7.1M
EPS (TTM):
-$0.32
Earnings Data
Next earnings date for PRQR
Mar 13
2025
Most recent earnings per share
-$0.11
Beat by $0.03
(Nov 7/2024)
Consensus Estimate
-$0.14
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PRQR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/13/2025 | Q4 | $7M | -- | -- | -$0.15 | -- |
| 11/07/2024 | Q3 | $12.3M | $4.2M | -$0.11 | -$0.14 | $0.03 |
| 08/08/2024 | Q2 | $11.2M | $6.8M | -$0.03 | -$0.17 | $0.14 |
| 05/09/2024 | Q1 | $2.9M | $4.8M | -$0.10 | -$0.16 | $0.06 |
| 03/13/2024 | Q4 | $15.9M | $3.5M | -$0.08 | -$0.12 | $0.04 |
| 11/07/2023 | Q3 | -- | -- | -$0.08 | -$0.13 | $0.05 |
| 08/03/2023 | Q2 | -- | -- | -$0.11 | -$0.12 | $0.01 |
| 05/16/2023 | Q1 | -- | -- | -$0.12 | -$0.10 | -$0.02 |
| 02/24/2023 | Q4 | -- | -- | -$0.19 | -$0.19 | -$0.00 |
| 11/09/2022 | Q3 | -- | -- | -$0.34 | -$0.23 | -$0.11 |
| 08/04/2022 | Q2 | -- | -- | -$0.22 | -$0.22 | -$0.00 |
| 05/05/2022 | Q1 | -- | -- | -$0.22 | -$0.28 | $0.05 |
| 02/24/2022 | Q4 | -- | -- | -$0.30 | -$0.12 | -$0.18 |
| 11/04/2021 | Q3 | -- | -- | -$0.26 | -$0.24 | -$0.02 |
| 08/05/2021 | Q2 | -- | -- | -$0.29 | -$0.27 | -$0.02 |
| 05/06/2021 | Q1 | -- | -- | -$0.30 | -$0.30 | -$0.00 |
| 02/25/2021 | Q4 | -- | -- | -$0.31 | -$0.31 | $0.00 |
| 11/16/2020 | Q3 | -- | -- | -$0.30 | -$0.39 | $0.09 |
| 08/06/2020 | Q2 | -- | -- | -$0.09 | -$0.35 | $0.26 |
| 05/07/2020 | Q1 | -- | -- | -$0.35 | -$0.36 | $0.01 |
| 02/26/2020 | Q4 | -- | -- | -$0.43 | -$0.37 | -$0.06 |
| 11/06/2019 | Q3 | -- | -- | -$0.34 | -$0.38 | $0.03 |
| 08/07/2019 | Q2 | -- | -- | -$0.34 | -$0.43 | $0.09 |
| 05/08/2019 | Q1 | -- | -- | -$0.40 | -$0.38 | -$0.02 |
| 02/27/2019 | Q4 | -- | -- | -$0.38 | -$0.30 | -$0.08 |
| 11/07/2018 | Q3 | -- | -- | -$0.21 | -$0.31 | $0.11 |
| 08/08/2018 | Q2 | -- | -- | -$0.27 | -$0.47 | $0.20 |
| 03/31/2018 | Q1 | -- | -- | -$0.40 | -$0.40 | -$0.00 |
| 02/28/2018 | Q4 | -- | -- | -$0.48 | -$0.45 | -$0.03 |
| 11/20/2017 | Q3 | -- | -- | -$0.49 | -$0.50 | $0.01 |
| 08/16/2017 | Q2 | -- | -- | -$0.55 | -$0.51 | -$0.04 |
| 03/31/2017 | Q1 | -- | -- | -$0.50 | -$0.51 | $0.01 |
| 02/28/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/14/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/17/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/19/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/23/2015 | Q3 | -- | -- | -- | -- | -- |
| 08/20/2015 | Q2 | -- | -- | -- | -- | -- |
| 05/28/2015 | Q1 | -- | -- | $0.01 | -- | -- |
| 03/02/2015 | Q4 | -- | -- | -- | -- | -- |
ProQR Therapeutics NV Earnings Questions
-
How Much did ProQR Therapeutics NV Generate in Revenue Last Quarter?
ProQR Therapeutics NV reported $4.2M worth of top line sales in its most recent quarter.
-
Did ProQR Therapeutics NV Beat Earnings Last Quarter?
ProQR Therapeutics NV announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.14 per share.
-
Is ProQR Therapeutics NV Profitable?
ProQR Therapeutics NV reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ProQR Therapeutics NV EPS Next Year?
ProQR Therapeutics NV's earnings are forecast to decrease from -$0.38 per share to -$0.45 per share next year representing a decrease of -48.58%.
-
When is ProQR Therapeutics NV's Earnings Date?
ProQR Therapeutics NV's next earnings date is March 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
